🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
41Score
DipBuster Score™
$319.14
$0.73 (-0.23%)
Live price · Source: Yahoo
52-Week Position
$281.00
31% of range
$404.87
Beta
0.778
Low vol
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta0.778
52W High$404.87
52W Low$281.00
DipBuster Brief
Key signals at a glance
Zone: Buy Zone
Neutral
Mid-Range Position (31% of 52-Week Range)
The stock sits in the middle of its annual range — no extreme dip opportunity, but also not overextended.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position31% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.778
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Recent director dealings and insider transactions at Stryker Corporation (SYK), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
| Date | Insider | Type | Shares |
|---|---|---|---|
| 2026-06-01 | Stiles Spencer S | SELL | 1,607 |
| 2026-05-28 | Fletcher Robert S | SELL | 125 |
| 2026-05-28 | Fletcher Robert S | SELL | 258 |
| 2026-05-28 | Fletcher Robert S | SELL | 1,067 |
| 2026-05-28 | Fletcher Robert S | SELL | 2,809 |
| 2026-05-28 | Fletcher Robert S | SELL | 165 |
| 2026-05-28 | Fletcher Robert S | SELL | 120 |
| 2026-05-26 | Stryker Ronda E | SELL | 3,707 |
| 2026-05-26 | Stryker Ronda E | SELL | 10,407 |
| 2026-05-26 | Stryker Ronda E | SELL | 44,060 |
Valuation
P/E RatioN/A
Market CapN/A
Beta0.778
Dividend/yrNone
52W High$404.87
52W Low$281.00
52-Week Range
$281.00Now$404.87
31% through annual range
From 52W High−21.2%
From 52W Low+13.6%
📖 Plain English Summary
Stryker Corporation is at 31% of its 52-week range. Beta 0.778 — tends to move less than the market.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for SYK
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — SYK
Heuristic · balance sheet, insider filings, price data, academic research
Stryker Corporation — DipBuster Score 41/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track Stryker Corporation free
Add SYK to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Freetrade
Simple investing app. Free ISA. UK and US stocks. FCA regulated.
Free share when you fund your account
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
28/25
Momentum & Volume
8/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
33
/100 · NEUTRAL
dip depth
23/25
oversold rsi
3/25
mean reversion
7/15
insider zone
0/25
capitulation
0/10
Technical signal only. Not financial advice.
Quick Take
🟡
Watch
DipBuster Score: 41/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replace…
Sector
Healthcare
Market
🇺🇸 US
CEO
Kevin A. Lobo
Staff
56,000 employees
Website